These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16336946)

  • 21. Effects of two cannabinoids upon abstinence signs in ethanol-dependent mice.
    Sprague GL; Craigmill AL
    Pharmacol Biochem Behav; 1978 Jul; 9(1):11-5. PubMed ID: 568289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.
    Kämpfer H; Bräutigam L; Geisslinger G; Pfeilschifter J; Frank S
    J Invest Dermatol; 2003 May; 120(5):880-90. PubMed ID: 12713596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.
    Oliva JM; Ortiz S; Palomo T; Manzanares J
    J Psychopharmacol; 2004 Mar; 18(1):59-65. PubMed ID: 15107186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum.
    Tzavara ET; Valjent E; Firmo C; Mas M; Beslot F; Defer N; Roques BP; Hanoune J; Maldonado R
    Eur J Neurosci; 2000 Mar; 12(3):1038-46. PubMed ID: 10762335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
    Aracil-Fernández A; Almela P; Manzanares J
    Addict Biol; 2013 Mar; 18(2):252-62. PubMed ID: 22017514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice.
    Valverde O; Maldonado R; Valjent E; Zimmer AM; Zimmer A
    J Neurosci; 2000 Dec; 20(24):9284-9. PubMed ID: 11125007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the arachidonic acid cascade in the hypersusceptibility to pentylenetetrazole-induced seizure during diazepam withdrawal.
    Mori T; Shimizu N; Shibasaki M; Suzuki T
    Biol Pharm Bull; 2012; 35(12):2243-6. PubMed ID: 23207777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesolimbic dopaminergic decline after cannabinoid withdrawal.
    Diana M; Melis M; Muntoni AL; Gessa GL
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10269-73. PubMed ID: 9707636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
    Nawata Y; Yamaguchi T; Yamamoto T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):93-4. PubMed ID: 22708263
    [No Abstract]   [Full Text] [Related]  

  • 32. Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.
    Aceto MD; Scates SM; Razdan RK; Martin BR
    J Pharmacol Exp Ther; 1998 Nov; 287(2):598-605. PubMed ID: 9808686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.
    Oliva JM; Ortiz S; Palomo T; Manzanares J
    J Neurochem; 2003 Apr; 85(1):94-104. PubMed ID: 12641731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
    Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Berrendero F; Maldonado R
    Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation.
    Cui SS; Bowen RC; Gu GB; Hannesson DK; Yu PH; Zhang X
    J Neurosci; 2001 Dec; 21(24):9867-76. PubMed ID: 11739594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
    Rao GK; Zhang W; Kaminski NE
    J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats.
    Lamota L; Bermudez-Silva FJ; Marco EM; Llorente R; Gallego A; Rodríguez de Fonseca F; Viveros MP
    Neuropharmacology; 2008 Jan; 54(1):194-205. PubMed ID: 17720206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.